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Background
Protection of bioreactors from viruses and mycoplasma
remains a challenge. While the risk of these contamina-
tions is known, and several recent high profile cases
have raised awareness of this risk, many bioreactors
remain unprotected. Currently available technologies,
such as high-temperature short-time treatment and
ultraviolet light treatment, can be difficult to implement
due to footprint, efficacy, and media compatibility
issues. Size exclusion nanofiltration may be a more ideal
technology for virus and mycoplasma protection, poten-
tially offering advantages in robustness, scalability, small
footprint, and media compatibility.
However, current virus removal filters, designed for
monoclonal antibody purification, are generally poorly
suited for cell culture media processes due to the large
membrane surface areas needed to achieve adequate
flow and capacity in a reasonable timeframe. Here we
evaluate a novel virus barrier filter specifically developed
for cell culture media applications.
Materials and Methods
The Viresolve®Barrier filter was evaluated for retention
of virus, bacteria and mycoplasma and for effects on cell
culture growth and product quality. Flow rate and capa-
city were benchmarked against existing commercially
available virus membranes in order to compare both the
performance and economics for the filtration of cell cul-
ture media and feeds.
Retention of microorganisms was performed at con-
stant pressure with both media and buffer utilizing
seven microorganisms (viruses, bacteria and myco-
plasma). Retention testing was performed in lab scale
devices with typical membrane samples expected to give
representative performance.
To demonstrate cell culture performance, Cellvento®
CHO-200 media and the corresponding feeds were pro-
cessed through a Viresolve® Barrier filter. 1H-NMR at
500 MHz, inductively coupled plasma/optical emission
spectrometry (ICP/OES) and reverse-phase LC-MSMS
were used to assess any effects of filtration on media
components. Fed batch studies were performed in shake
flask cultures using recombinant mAb producing CHO
cells. Cell culture performance and protein quality were
evaluated and compared to a 0.2 µm Millipore Express®
filtered control.
Results
Preliminary testing has shown high retention for small
viruses as well as complete removal (up to detection
limit) of large viruses, bacteria and mycoplasma (Table
1). Both standard and difficult-to-retain bacteria and
mycoplasma were tested. As the filter is gamma stable
and steam in place (SIP) compatible it could be used in
place of the standard 0.2 µm filter.
Virus filtration is often perceived as unsuitable for cell
culture media due to its high cost and large footprint.
Over a six hour filtration process, Viresolve®Barrier fil-
ter had a volumetric throughput approximately 3 to 30
times higher than other commercially available virus
filters.
It is crucial that a virus barrier filter does not remove
any critical media components or impact cell culture per-
formance. A multidimensional analysis of the performance
of filtered media in recombinant mAb-producing cell cul-
tures revealed no impact. Media and feed components
were unaffected by filtration through the Viresolve®Barrier
filter as evaluated by 1H-NMR, ICP/OES and LC-MSMS.EMD Millipore Corporation, Bedford, MA, 01730, USA
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Table 1 Microorganism retention testing usingViresolve® Barrier filter.
Type Organism Description TypicalLog Reduction
Value
Viruses Minute Virus of Mice (MVM) Model parvovirus, reported contaminant of manufacturing operations,
target organism
4.8




Bacteria Brevundimonasdiminuta Standard model bacteria for ASTM sterilizing grade designation >8.0
Leptonemaillini Model spirochete bacteria, difficult to retain on sterilizing grade filters >8.0
Mycoplasma Acholeplasmalaidlawii Standard model mycoplasma, pleomorphic, retained by 0.1 µm filters >8.0
Mycoplasma orale Model mycoplasma, small and pleomorphic, difficult to retain on 0.1 µm
filters
>8.0
Figure 1 (a) NMR fingerprinting of media pre-filtration (dark blue) or post Viresolve®Barrier filtration (light blue) showed no change in
media composition. (b): Cell growth of fed-batch cultures using Viresolve®Barrier filtered media and feeds (VB+) or 0.22µM filtered media and
feeds (VB-). (c): Product quality of the mAb is unchanged by virus filtration of the media and feeds. All attributes displayed as a ratio of VB+/VB-.
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Cultures showed no differences in cell growth or titer rela-
tive to the sterile filtered control. Furthermore secreted
antibody showed no differences in aggregation profiles,
charge variants or glycosylation patterns (Figure 1).
Conclusions
The risk of virus contamination in the bioreactor
remains a concern for biotherapeutic manufacturers as
no single technology provides sufficient, economical
protection while minimizing the impact to cell culture.
This study evaluated a virus barrier filter that provides
an efficient and easy way to protect a bioreactor from
adventitious virus.
Study results demonstrated high retention for small
viruses and detection limit retention of large viruses,
mycoplasma and bacteria, while requiring less than half
the area of commercial virus filters. Since the filter is
stable to gamma and SIP sterilization, it could be used
in place of a sterile filter. Favorable cell culture perfor-
mance and extensive analytical analysis indicated little
change in the media composition after virus barrier fil-
tration. The protein quality attributes were equivalent to
those from a control process using standard 0.2 µm
filtration.
Results from this study suggest that filtration with a
Viresolve®Barrierfilter can provide optimal filtration per-
formance, high retention, and minimal cell culture
impact as well as providing a viable option to improve
the overall virus safety strategy for chemically defined
cell culture media.
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